Insilico Medicine Secures $5 Million Milestone from Menarini Group After MEN2501 First-in-Human Success
In a significant stride for AI-driven oncology drug discovery, Insilico Medicine, a clinical-stage biotechnology company leveraging generative artificial intelligence, announced ...
